A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months. 

Ben Fidler Member since June 22, 2024

Loading + Follow Following